(TOP (S (NP-SBJ (CD Two)
                (JJ Japanese)
                (NNS scientists))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ (PRP they))
                     (VP (VBD discovered)
                         (NP (NP (DT an)
                                 (NN antibody))
                             (SBAR (WHNP-1 (IN that))
                                   (, ,)
                                   (S (PP-LOC (IN in)
                                              (NP (NN laboratory)
                                                  (NML (NN test)
                                                       (HYPH -)
                                                       (NN tube))
                                                  (NNS experiments)))
                                      (, ,)
                                      (NP-SBJ-2 (-NONE- *T*-1))
                                      (VP (VBZ kills)
                                          (NP (ADJP (NNP AIDS)
                                                    (HYPH -)
                                                    (VBN infected))
                                              (NNS cells))
                                          (SBAR-TMP (IN while)
                                                    (S (NP-SBJ (-NONE- *PRO*-2))
                                                       (VP (VBG preserving)
                                                           (NP (JJ healthy)
                                                               (NNS cells)))))))))))))
        (. .)))

(TOP (S (SBAR-ADV (IN If)
                  (S (NP-SBJ (JJ further)
                             (NNS experiments))
                     (VP (VBP are)
                         (ADJP-PRD (JJ successful)))))
        (, ,)
        (NP-SBJ (DT the)
                (NN work))
        (VP (MD would)
            (VP (VB represent)
                (NP (NP (DT a)
                        (JJ major)
                        (NN advance))
                    (PP (IN in)
                        (NP (NP (NN research))
                            (PP (IN on)
                                (NP (NML (VBN acquired)
                                         (JJ immune)
                                         (NN deficiency))
                                    (NN syndrome))))))))
        (. .)))

(TOP (S (NP-SBJ-1 (NP (DT The)
                      (NN drug)
                      (NNP AZT))
                  (, ,)
                  (NP (NP (DT the)
                          (JJ only)
                          (NN treatment))
                      (RRC (ADVP-TMP (RB currently))
                           (PP (IN on)
                               (NP (DT the)
                                   (NN market)))))
                  (, ,))
        (VP (VBZ claims)
            (S (NP-SBJ (-NONE- *PRO*-1))
               (ADVP (RB only))
               (VP (VP (TO to)
                       (VP (VB help)
                           (S (NP-SBJ (-NONE- *PRO*))
                              (VP (VB stop)
                                  (NP (NP (DT the)
                                          (NN spread))
                                      (PP (IN of)
                                          (NP (NNP AIDS))))))))
                   (, ,)
                   (RB not)
                   (VP (TO to)
                       (VP (VB cure)
                           (NP (PRP it)))))))
        (. .)))

(TOP (S (CC But)
        (NP-SBJ (NP (NP (JJ several)
                        (NNS analysts))
                    (CC and)
                    (NP (JJ Japanese)
                        (NNS scientists)))
                (ADJP (JJ familiar)
                      (PP (IN with)
                          (NP (NP (DT the)
                                  (NN study))
                              (, ,)
                              (SBAR (WHNP-2 (WDT which))
                                    (S (NP-SBJ-1 (-NONE- *T*-2))
                                       (VP (VBD was)
                                           (VP (VBN announced)
                                               (NP (-NONE- *-1))
                                               (PP-LOC (IN at)
                                                       (NP (NP (DT a)
                                                               (NN conference))
                                                           (PP-LOC (IN in)
                                                                   (NP (NNP Nagoya)))))
                                               (NP-TMP (NN yesterday))))))
                              (, ,)))))
        (VP (VBD expressed)
            (NP (NN skepticism))
            (PP-CLR (IN over)
                    (NP (NP (DT the)
                            (NN significance))
                        (PP (IN of)
                            (NP (DT the)
                                (NNS results))))))
        (. .)))

(TOP (S (CC And)
        (NP-SBJ (NP (DT the)
                    (NNS researchers))
                (NP (PRP themselves)))
        (VP (VBD acknowledged)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ (PRP they))
                     (ADVP (RB still))
                     (VP (MD must)
                         (VP (VB do)
                             (NP (ADJP (RB much)
                                       (JJR more))
                                 (NN work))
                             (SBAR-TMP (IN before)
                                       (S (NP-SBJ (PRP they))
                                          (VP (MD can)
                                              (VP (VB say)
                                                  (SBAR (IN whether)
                                                        (S (NP-SBJ (DT the)
                                                                   (NN treatment))
                                                           (VP (MD would)
                                                               (ADVP (RB actually))
                                                               (VP (VB cure)
                                                                   (NP (NNS humans)))))))))))))))
        (. .)))

(TOP (S (NP-SBJ (NP (NNP Shin)
                    (NNP Yonehara))
                (, ,)
                (NP (NP (DT a)
                        (NN research)
                        (NN scientist))
                    (PP-LOC (IN at)
                            (NP (NP (DT the)
                                    (NNP Tokyo)
                                    (NNP Metropolitan)
                                    (NNP Institute))
                                (PP (IN of)
                                    (NP (NNP Medical)
                                        (NNP Science))))))
                (, ,))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ (NP (DT the)
                                 (NN antibody))
                             (SBAR (WHNP-2 (-NONE- 0))
                                   (S (NP-SBJ (PRP he))
                                      (VP (VBD discovered)
                                          (NP (-NONE- *T*-2))))))
                     (VP (VBZ works)
                         (PP-MNR (IN by)
                                 (S-NOM (NP-SBJ (-NONE- *PRO*))
                                        (VP (VBG recognizing)
                                            (NP (NP (NP (DT an)
                                                        (NN antigen))
                                                    (VP (VBN called)
                                                        (NP-3 (-NONE- *))
                                                        (S-CLR (NP-SBJ (-NONE- *PRO*-3))
                                                               (NP-PRD (DT a)
                                                                       (NNP Fas)
                                                                       (HYPH -)
                                                                       (NNP antigen)))))
                                                (, ,)
                                                (SBAR (WHNP-1 (WDT which))
                                                      (S (NP-SBJ (-NONE- *T*-1))
                                                         (VP (VBZ is)
                                                             (ADJP-PRD (JJ characteristic)
                                                                       (PP (IN of)
                                                                           (NP (DT an)
                                                                               (JJ infected)
                                                                               (NN cell)))))))))))))))
        (. .)))

(TOP (S (NP-SBJ (DT The)
                (NN antibody))
        (ADVP-TMP (RB then))
        (VP (VBZ kills)
            (NP (DT the)
                (NN cell)))
        (. .)))

(TOP (S (NP-SBJ (NP (NNP Dr.)
                    (NNP Yonehara))
                (CC and)
                (NP (NP (PRP$ his)
                        (NN partner))
                    (, ,)
                    (NP (NP (NNP Nobuyuki)
                            (NNP Kobayashi))
                        (PP (IN of)
                            (NP (NNP Yamaguchi)
                                (NNP University))))
                    (, ,)))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ (PRP$ their)
                             (NNS experiments))
                     (VP (VBD showed)
                         (SBAR (IN that)
                               (S (NP-SBJ (DT the)
                                          (NN antibody))
                                  (VP (VBD wiped)
                                      (PRT (RP out))
                                      (NP (NP (DT an)
                                              (NN average))
                                          (PP (IN of)
                                              (NP (NP (CD 60)
                                                      (NN %))
                                                  (PP (IN of)
                                                      (NP (ADJP (NNP AIDS)
                                                                (HYPH -)
                                                                (VBN infected))
                                                          (NNS cells))))))
                                      (PP-TMP (IN within)
                                              (NP (CD three)
                                                  (NNS days))))))))))
        (. .)))

(TOP (S (S-TPC-1 (PP-LOC (IN In)
                         (NP (NP (DT some))
                             (PP (IN of)
                                 (NP (DT the)
                                     (NNS experiments)))))
                 (, ,)
                 (NP-SBJ (PRP it))
                 (VP (VBD killed)
                     (NP (QP (RB almost)
                             (PDT all))
                         (DT the)
                         (JJ infected)
                         (NNS cells))))
        (, ,)
        (NP-SBJ (DT the)
                (NNS researchers))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (-NONE- *T*-1))))
        (. .)))

(TOP (S (ADVP (RB Meanwhile))
        (, ,)
        (NP-SBJ-1 (NP (QP (JJR fewer)
                          (IN than)
                          (CD 10))
                      (NN %))
                  (PP (IN of)
                      (NP (DT the)
                          (JJ healthy)
                          (NNS cells))))
        (VP (VBD were)
            (VP (VBN killed)
                (NP (-NONE- *-1))))
        (. .)))

(TOP (S (NP-SBJ (DT The)
                (CD two))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ (PRP they))
                     (VP (MD must)
                         (ADVP (RB still))
                         (VP (VP (VB do)
                                 (NP (JJR more)
                                     (NN laboratory)
                                     (NNS tests)))
                             (, ,)
                             (RB then)
                             (VP (NN experiment)
                                 (PP-CLR (IN on)
                                         (NP (NNS animals)))))))))
        (. .)))

(TOP (S (NP-SBJ (PRP They))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ-1 (PRP they))
                     (VP (VBD hoped)
                         (S (NP-SBJ (-NONE- *PRO*-1))
                            (VP (TO to)
                                (VP (VB conduct)
                                    (NP (NNS tests))
                                    (PP-CLR (IN on)
                                            (NP (NP (JJ human)
                                                    (NNS patients))
                                                (PP-LOC (IN in)
                                                        (NP (DT the)
                                                            (NNP U.S.)))))
                                    (PP-TMP (IN by)
                                            (NP (ADVP (RB late))
                                                (JJ next)
                                                (NN year))))))))))
        (. .)))

(TOP (S (S-TPC-2 (NP-SBJ-1 (NNP Japan))
                 (VP (VBZ does)
                     (RB n't)
                     (VP (VB have)
                         (NP (JJ enough)
                             (NNP AIDS)
                             (NNS patients)
                             (S (NP-SBJ (-NONE- *PRO*-1))
                                (VP (TO to)
                                    (VP (VB do)
                                        (NP (JJ significant)
                                            (NN experimentation))
                                        (PP-LOC (IN in)
                                                (NP (DT that)
                                                    (NN country))))))))))
        (, ,)
        (NP-SBJ (PRP they))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (-NONE- *T*-2))))
        (. .)))

(TOP (S (NP-SBJ (DT The)
                (NN announcement))
        (VP (VP (VBD got)
                (NP (JJ wide)
                    (NN exposure))
                (PP-LOC (IN in)
                        (NP (DT the)
                            (JJ Japanese)
                            (NNS media))))
            (, ,)
            (CC and)
            (ADVP (RB even))
            (VP (VBD moved)
                (NP (DT some)
                    (NN pharmaceutical)
                    (NNS stocks))
                (NP-TMP (NN yesterday))))
        (. .)))

(TOP (S (CC But)
        (NP-SBJ (NP (NNP Takashi)
                    (NNP Kitamura))
                (, ,)
                (NP (NP (NP (NN director))
                        (PP (IN of)
                            (NP (NP (DT the)
                                    (NN biology)
                                    (NN department))
                                (PP-LOC (IN at)
                                        (NP (NP (NP (NNP Japan)
                                                    (POS 's))
                                                (NNP National)
                                                (NNP Institute))
                                            (PP (IN of)
                                                (NP (NNP Health))))))))
                    (CC and)
                    (NP (NP (NN secretary))
                        (PP (IN of)
                            (NP (NP (DT the)
                                    (NN government)
                                    (POS 's))
                                (NML (NNP AIDS)
                                     (HYPH -)
                                     (NN research))
                                (NN center)))))
                (, ,))
        (VP (VBD said)
            (, ,)
            (`` ``)
            (S (NP-SBJ (PRP I))
               (VP (VBP 'm)
                   (RB not)
                   (ADJP-PRD (RB so)
                             (JJ optimistic)
                             (PP (IN of)
                                 (NP (NP (PRP$ its)
                                         (JJ future)
                                         (NN use))
                                     (PP-LOC (IN in)
                                             (NP (JJ therapeutic)
                                                 (NNS methods)))))))))
        (. .)
        ('' '')))

(TOP (S (NP-SBJ (PRP He))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ-1 (DT some)
                               (JJ infected)
                               (NNS cells))
                     (VP (VP (MD may)
                             (RB not)
                             (VP (VB have)
                                 (NP (DT the)
                                     (JJ relevant)
                                     (NN antigen))))
                         (CC and)
                         (ADVP (RB so))
                         (VP (MD would)
                             (RB n't)
                             (VP (VB be)
                                 (VP (VBN killed)
                                     (NP (-NONE- *-1))
                                     (PP-TMP (ADVP (RB even))
                                             (IN after)
                                             (NP (NP (NN exposure))
                                                 (PP (IN to)
                                                     (NP (DT the)
                                                         (NN antibody))))))))))))
        (. .)))

(TOP (SINV (`` ``)
           (S-TPC-2 (NP-SBJ-1 (DT The)
                              (NNS results))
                    (VP (VBP seem)
                        (S (NP-SBJ (-NONE- *-1))
                           (VP (TO to)
                               (VP (VB be)
                                   (ADJP-PRD (RB very)
                                             (JJ premature)))))))
           (, ,)
           ('' '')
           (VP (VBD said)
               (S (-NONE- *T*-2)))
           (NP-SBJ (NP (NNP Mitsuru)
                       (NNP Miyata))
                   (, ,)
                   (NP (NP (NN editor))
                       (PP (IN of)
                           (NP (NP (NNP Nikkei)
                                   (NNP Biotechnology))
                               (, ,)
                               (NP (DT a)
                                   (VBG leading)
                                   (JJ Japanese)
                                   (NN industry)
                                   (NN newsletter))))))
           (. .)))

(TOP (S (NP-SBJ (NNP Dr.)
                (NNP Kobayashi))
        (VP (VBD responded)
            (SBAR (IN that)
                  (S (NP-SBJ (PRP he))
                     (VP (VBD thought)
                         (SBAR (-NONE- 0)
                               (S (NP-SBJ (DT the)
                                          (NN antibody))
                                  (VP (MD could)
                                      (ADVP (RB potentially))
                                      (VP (VB kill)
                                          (NP (DT all)
                                              (JJ infected)
                                              (NNS cells))))))))))
        (. .)))

(TOP (S (CC But)
        (NP-SBJ (NP (PRP he))
                (CC and)
                (NP (NNP Dr.)
                    (NNP Yonehara)))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (NP-SBJ (EX there))
                     (VP (VBD were)
                         (ADVP (RB still))
                         (NP-PRD (NP (JJ several)
                                     (NNS uncertainties))
                                 (, ,)
                                 (RRC (ADVP (RB particularly))
                                      (PP (VBG regarding)
                                          (NP (JJ possible)
                                              (NN side)
                                              (NNS effects)))))))))
        (. .)))

(TOP (SINV (`` ``)
           (S-TPC-1 (S (NP-SBJ (PRP$ Our)
                               (NN antibody))
                       (ADVP (RB specifically))
                       (VP (VBD killed)
                           (NP (JJ infected)
                               (NNS cells))
                           (PP-MNR (IN at)
                                   (NP (DT a)
                                       (ADJP (RB very)
                                             (JJ low))
                                       (NN dose)))))
                    (, ,)
                    (CC but)
                    (S (NP-SBJ (PRP it))
                       (VP (MD can)
                           (ADVP (RB also))
                           (VP (VB kill)
                               (NP (JJ other)
                                   (NNS cells))))))
           (, ,)
           ('' '')
           (VP (VBD said)
               (S (-NONE- *T*-1)))
           (NP-SBJ (NNP Dr.)
                   (NNP Yonehara))
           (. .)))

(TOP (S (`` ``)
        (NP-SBJ (PRP We))
        (VP (VBP do)
            (RB n't)
            (VP (VB know)
                (NP (NP (DT the)
                        (NN effect))
                    (PP (IN of)
                        (NP (PRP$ our)
                            (NN antibody)))
                    (PP (IN on)
                        (NP (DT the)
                            (JJ human)
                            (NN body))))))
        (. .)
        ('' '')))

(TOP (S (S (NP-SBJ-1 (NNP AIDS))
           (VP (VBZ is)
               (RB n't)
               (VP (VBN considered)
                   (S (NP-SBJ (-NONE- *-1))
                      (NP-PRD (NP (DT a)
                                  (JJ widespread)
                                  (NN problem))
                              (PP-LOC (IN in)
                                      (NP (NNP Japan))))))))
        (: --)
        (S (NP-SBJ (DT the)
                   (NN government))
           (VP (VBZ reports)
               (NP (NP (QP (IN about)
                           (CD 1,000))
                       (VBN known)
                       (NNS carriers))
                   (PP (IN of)
                       (NP (DT the)
                           (NN virus))))))
        (: --)
        (CC but)
        (S (NP-SBJ-2 (JJ many)
                     (NNS companies))
           (VP (VBP have)
               (VP (VBN poured)
                   (NP (JJ substantial)
                       (NNS resources))
                   (PP-CLR (IN into)
                           (NP (NN research)))
                   (PP-TMP (IN in)
                           (NP (JJ recent)
                               (NNS years)))
                   (, ,)
                   (S-ADV (NP-SBJ-3 (-NONE- *PRO*-2))
                          (VP (VBG hoping)
                              (S (NP-SBJ (-NONE- *PRO*-3))
                                 (VP (TO to)
                                     (VP (VB cash)
                                         (PRT (RP in))
                                         (PP-CLR (IN on)
                                                 (NP (DT a)
                                                     (JJ possible)
                                                     (NN cure)))))))))))
        (. .)))

(TOP (S (NP-SBJ (NNP Dr.)
                (NNP Kitamura))
        (VP (VBD said)
            (SBAR (SBAR (-NONE- 0)
                        (S (NP-SBJ (QP (IN about)
                                       (CD 35))
                                   (NNS projects))
                           (VP (VBP are)
                               (ADVP-TMP (RB currently))
                               (PP-PRD (IN under)
                                       (NP (NN way)))
                               (PP-LOC (IN in)
                                       (NP (NNP Japan))))))
                  (, ,)
                  (CC and)
                  (SBAR (IN that)
                        (S (NP-SBJ (NP (JJ Japanese)
                                       (NNS researchers))
                                   (PP-TMP (IN in)
                                           (NP (DT the)
                                               (JJ past)
                                               (NN year))))
                           (VP (VBP have)
                               (VP (VBN made)
                                   (S (ADJP-PRD (JJ available)
                                                (PP (-NONE- *ICH*-1))
                                                (PP (-NONE- *ICH*-2)))
                                      (NP-SBJ (CD three)
                                              (JJ possible)
                                              (NNS cures))
                                      (PP-1 (IN to)
                                            (NP (JJ American)
                                                (NNS researchers)))
                                      (PP-2 (IN for)
                                            (NP (JJ clinical)
                                                (NNS tests))))))))))
        (. .)))

(TOP (S (NP-SBJ (PRP He))
        (VP (VBD said)
            (SBAR (IN that)
                  (S (SBAR-TMP (WHADVP-1 (WRB when))
                               (S (NP-SBJ (NP (NNS scientists))
                                          (PP (IN from)
                                              (NP (DT the)
                                                  (CD two)
                                                  (NNS countries))))
                                  (VP (VBP meet)
                                      (ADVP (RB again))
                                      (PP-TMP (IN in)
                                              (NP (NNP January)))
                                      (PP-LOC (IN in)
                                              (NP (NNP New)
                                                  (NNP Orleans)))
                                      (ADVP-TMP (-NONE- *T*-1)))))
                     (, ,)
                     (NP-SBJ (DT the)
                             (NNP Japanese))
                     (VP (MD will)
                         (VP (VB present)
                             (NP (ADJP (QP (ADVP (RB at)
                                                 (RBS least))
                                           (CD three))
                                       (JJR more))
                                 (NNS drugs))
                             (PP-CLR (IN for)
                                     (NP (JJ human)
                                         (NN testing))))))))
        (. .)))

(TOP (S (NP-SBJ (NNP AZT))
        (VP (VBZ is)
            (NP-PRD (NP (NP (DT the)
                            (NN world)
                            (POS 's))
                        (JJ only)
                        (NN prescription)
                        (NN medicine))
                    (VP (VBN approved)
                        (NP (-NONE- *))
                        (PP-CLR (IN for)
                                (S-NOM (NP-SBJ (-NONE- *PRO*))
                                       (VP (VBG treating)
                                           (NP (DT the)
                                               (NN disease))))))))
        (. .)))

(TOP (S (NP-SBJ (NP (NNP Wellcome)
                    (NNP PLC))
                (, ,)
                (NP (DT a)
                    (JJ major)
                    (JJ British)
                    (NN pharmaceutical)
                    (NN maker))
                (, ,))
        (VP (VBZ sells)
            (NP (DT the)
                (NN drug))
            (PP-MNR (IN under)
                    (NP (NP (DT the)
                            (NN name))
                        (NP (NNP Retrovir)))))
        (. .)))

(TOP (S (NP-SBJ-1 (DT A)
                  (NNP Wellcome)
                  (NN spokesman))
        (VP (VBD declined)
            (S (NP-SBJ (-NONE- *PRO*-1))
               (VP (TO to)
                   (VP (VB comment)
                       (PP-CLR (IN on)
                               (NP (NP (DT the)
                                       (NN discovery))
                                   (PP (IN of)
                                       (NP (DT the)
                                           (NN antibody)))
                                   (PP-LOC (IN in)
                                           (NP (NNP Japan)))))))))
        (. .)))

(TOP (S (CC But)
        (NP-SBJ (NP (NNP Andrew)
                    (NNP Porter))
                (, ,)
                (NP (NP (DT a)
                        (NML (NN drug)
                             (HYPH -)
                             (NN industry))
                        (NN analyst))
                    (PP-LOC (IN at)
                            (NP (NP (NNP Nikko)
                                    (NNPS Securities)
                                    (NNP Co.))
                                (PP-LOC (IN in)
                                        (NP (NNP London))))))
                (, ,))
        (VP (VBD said)
            (SBAR (-NONE- 0)
                  (S (SBAR-ADV (IN if)
                               (S (NP-SBJ-2 (DT the)
                                            (NN product))
                                  (VP (VBD were)
                                      (S (NP-SBJ-1 (-NONE- *-2))
                                         (VP (TO to)
                                             (VP (VB be)
                                                 (ADVP-MNR (RB successfully))
                                                 (VP (VBN developed)
                                                     (NP (-NONE- *-1)))))))))
                     (NP-SBJ (PRP it))
                     (VP (MD would)
                         (VP (VB represent)
                             (`` ``)
                             (NP (NP (DT a)
                                     (JJ potential)
                                     (NN threat))
                                 (PP (IN to)
                                     (NP (NP (DT the)
                                             (NML (JJ long)
                                                  (HYPH -)
                                                  (NN term))
                                             (NN viability))
                                         (PP (IN of)
                                             (NP (NNP Retrovir)))))))))))
        (. .)))

